Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
TNF-alpha Recombinant Murine Protein Workflow
2026-09-05
Build reproducible apoptosis and inflammation assays with a defined, trimeric murine cytokine rather than relying on poorly characterized conditioned media. This workflow uses TNF-alpha as a receptor-initiated benchmark alongside RNA Pol II degradation studies, helping separate inflammatory signaling from transcription-independent cell death.
-
Luminescent ATP Cell Viability Assay Kit I
2026-09-04
This scenario-based guide explains how Luminescent ATP Cell Viability Assay Kit I (SKU K2041) supports sensitive cell viability measurement, cytotoxicity testing, and proliferation studies. It covers assay principles, experimental design, protocol parameters, interpretation limits, and practical vendor-selection considerations for reproducible laboratory workflows.
-
Hoe 140: Potent Bradykinin Antagonism In Vitro
2026-09-04
Hock and colleagues characterized Hoe 140 as a structurally distinctive, highly potent bradykinin antagonist using receptor-binding, isolated-organ, and endothelial-cell assays. The study established a major potency advance over an earlier peptide antagonist while also showing inhibition of bradykinin-dependent vascular signaling, providing a foundation for later bradykinin-pathway pharmacology.
-
Amikacin Sulfate: From Mechanism to Translation
2026-09-03
Amikacin Sulfate is more than a conventional aminoglycoside benchmark. Its value in non-tuberculous mycobacterial research lies in connecting 30S ribosomal targeting with intracellular exposure, granulomatous tissue distribution, and delivery-led improvements in therapeutic index. This article outlines a translational framework for validating Amikacin across cellular, animal, and next-generation formulation studies.
-
Gastrodin, AT1 Signaling, and Reactive Astrocytes
2026-09-03
A 2024 European Journal of Neuroscience study used a microglia-conditioned medium model to show that gastrodin reshapes renin–angiotensin system, SIRT3, inflammatory, and neurotrophic responses in reactive astrocytes. Pharmacological AT1 inhibition supported a role for AT1 signaling in astrocyte phenotype regulation, while the cellular design also defines important limits for translation to brain disease models.
-
S-Nitrosylation Coordinates Aluminum Resistance
2026-09-02
A 2026 Molecular Plant study identifies nitric oxide-dependent S-nitrosylation as a mechanism that differentially regulates STOP1 and STAR1 in Arabidopsis. The findings connect STOP1-driven external aluminum exclusion with STAR1/ALS3-mediated internal sequestration and provide a framework for testing redox-sensitive cysteine regulation using reversible thiol labeling.
-
Amikacin Sulfate: From Intracellular Killing to Delivery
2026-09-02
Amikacin Sulfate is more than a conventional aminoglycoside assay reagent: it is a translational probe for understanding how antibacterial activity, intracellular exposure, tissue targeting, and microbiome-aware discovery intersect. This article outlines a practical framework for moving from 30S ribosome mechanism to reproducible NTM models and delivery strategies.
-
FUS–SMN Phase Separation in Neuronal Granules
2026-09-01
Wang and Li show that asymmetric arginine dimethylation enables FUS to engage oligomeric SMN through multivalent Tudor-domain interactions, promoting phase separation and neuronal granule formation. Their rescue experiments connect this molecular mechanism to axonal mRNA distribution, axon growth, and neuronal function, while highlighting SMN valency as a disease-relevant variable in spinal muscular atrophy.
-
EPZ-6438: An Assay-First EZH2 Inhibitor Guide
2026-09-01
Explore EPZ-6438 as an EZH2 inhibitor through an assay-first lens that connects PRC2 biology, H3K27me3 pharmacodynamics, and HPV-associated cervical cancer research. Learn how to separate target engagement from downstream cytotoxicity and design more interpretable experiments.
-
Ionophore Toxicity in Animals: Mechanisms and Evidence
2026-08-31
Ekinci, Chłodowska, and Olejnik integrate clinical observations with molecular toxicology to explain why polyether ionophores can damage myocardial and skeletal muscle in animals. The review’s main practical contribution is a framework linking dose, species, age, cation dysregulation, mitochondrial dysfunction, and tiamulin–ionophore interactions, while identifying important gaps for safer veterinary use and drug development.
-
Pseudo-UTP Workflow for Stable mRNA Synthesis
2026-08-31
Build a controlled in vitro transcription workflow with Pseudo-UTP to test RNA stability enhancement, translation, and immune-response tradeoffs. The guide pairs nucleotide substitution with UTR optimization, using the TMSB10 reference study to design more informative mRNA vaccine development assays.
-
Sodium phosphate dibasic: Assay Matrix Control
2026-08-30
Sodium phosphate dibasic supports reproducible pH control, but buffer selection must account for assay chemistry, organism sensitivity, and matrix effects. This guide connects Na2HPO4 handling with lessons from aquatic toxicity study design to improve biochemical and molecular biology workflows.
-
BODIPY 581/591 C11 in Osteoblast Ferroptosis
2026-08-29
Discover how the ratiometric fluorescent probe BODIPY 581/591 C11 can distinguish membrane lipid oxidation from broader oxidative stress in osteoblast ferroptosis studies. This guide translates NRF2/FSP1 findings into more rigorous assay design, controls, and interpretation.
-
Streptavidin-HyperFluor 647 Workflow Guide
2026-08-28
Build lower-background workflows for microscopy, flow cytometry, FRET, and biotinylated antibody detection with a red-emitting streptavidin probe. This guide also explains when the conjugate complements—and when it cannot replace—the biotin-free BmTyr proximity-labeling platform.
-
Safe DNA Gel Stain for Safer Gel Imaging
2026-08-28
Safe DNA Gel Stain supports high-sensitivity DNA and RNA gel imaging while enabling blue-light workflows that can reduce UV exposure during band selection. This practical guide connects stain choice with cloning, RNAi validation, and troubleshooting in applied molecular biology.